Syneron Medical (Nasdaq: ELOS) reported earnings on Feb. 12. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Dec. 31 (Q4), Syneron Medical beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share expanded.

Gross margins expanded, operating margins dropped, net margins expanded.

Revenue details
 Syneron Medical chalked up revenue of $72.8 million. The four analysts polled by S&P Capital IQ expected to see revenue of $70.6 million on the same basis. GAAP reported sales were 19% higher than the prior-year quarter's $61.0 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.11. The four earnings estimates compiled by S&P Capital IQ predicted $0.09 per share. GAAP EPS were $0.14 for Q4 compared to -$0.23 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 49.5%, 30 basis points better than the prior-year quarter. Operating margin was -2.3%, 4,090 basis points worse than the prior-year quarter. Net margin was 7.1%, 2,030 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $71.7 million. On the bottom line, the average EPS estimate is $0.12.

Next year's average estimate for revenue is $299.1 million. The average EPS estimate is $0.66.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 706 members out of 740 rating the stock outperform, and 34 members rating it underperform. Among 211 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 205 give Syneron Medical a green thumbs-up, and six give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Syneron Medical is buy, with an average price target of $16.38.

Is Syneron Medical the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.